An investigational vaccine developed by Moderna is being tested for safety and immune response in Seattle and 3 other cities.
New study calculates risk-based approach to detect the most cancers with the fewest exams.
Lisa Jackson, MD, MPH, Kaiser Permanente Washington senior investigator, recounts the genesis of a groundbreaking vaccine.
Dr. Sascha Dublin tells how studies of KP electronic health record data can improve COVID-19 treatment and prevention.
A registry started by KPWHRI last year has sped up studies needed to protect the world against the novel coronavirus.
Take these tips from researchers on the Society of Behavioral Medicine’s Physical Activity Special Interest Group.
Dr. Jennifer Nelson explains how Kaiser Permanente scientists are helping the CDC and FDA keep an eye out for rare adverse events.